Cambridge Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $235K | Sell |
|
|||||
|
2024
Q4 | $252K | Hold |
|
|||||
|
2024
Q3 | $275K | Buy |
|
|||||
|
2024
Q2 | $262K | Buy |
|
|||||
|
2024
Q1 | $222K | Sell |
|
|||||
|
2023
Q4 | $234K | Sell |
|
|||||
|
2023
Q3 | $306K | Sell |
|
|||||
|
2023
Q2 | $359K | Sell |
|
|||||
|
2023
Q1 | $476K | Sell |
|
|||||
|
2022
Q4 | $602K | Sell |
|
|||||
|
2022
Q3 | $525K | Buy |
|
|||||
|
2022
Q2 | $628K | Sell |
|
|||||
|
2022
Q1 | $624K | Sell |
|
|||||
|
2021
Q4 | $720K | Buy |
|
|||||
|
2021
Q3 | $496K | Sell |
|
|||||
|
2021
Q2 | $456K | Sell |
|
|||||
|
2021
Q1 | $430K | Buy |
|
|||||
|
2020
Q4 | $437K | Sell |
|
|||||
|
2020
Q3 | $432K | Buy |
|
|||||
|
2020
Q2 | $384K | Sell |
|
|||||
|
2020
Q1 | $407K | Buy |
|
|||||
|
2019
Q4 | $456K | Buy |
|
|||||
|
2019
Q3 | $417K | Sell |
|
|||||
|
2019
Q2 | $509K | Sell |
|
|||||
|
2019
Q1 | $665K | Buy |
|
|||||
|
2018
Q4 | $682K | Buy |
|
|||||
|
2018
Q3 | $615K | Sell |
|
|||||
|
2018
Q2 | $626K | Buy |
|
|||||
|
2018
Q1 | $611K | Buy |
|
|||||
|
2017
Q4 | $599K | Buy |
|
|||||
|
2017
Q3 | $532K | Buy |
|
|||||
|
2017
Q2 | $500K | Sell |
|
|||||
|
2017
Q1 | $532K | Sell |
|
|||||
|
2016
Q4 | $557K | Buy |
|
|||||
|
2016
Q3 | $503K | Sell |
|
|||||
|
2016
Q2 | $604K | Buy |
|
|||||
|
2016
Q1 | $507K | Buy |
|
|||||
|
2015
Q4 | $471K | Sell |
|
|||||
|
2015
Q3 | $491K | Sell |
|
|||||
|
2015
Q2 | $542K | Buy |
|
|||||
|
2015
Q1 | $266K | Sell |
|
|||||
|
2014
Q4 | $506K | Buy |
|